Skip to main content
PMC home page
Gut logoLink to Gut
. 1996 Nov;39(5):741–747. doi: 10.1136/gut.39.5.741

Oxytocin increases thresholds of colonic visceral perception in patients with irritable bowel syndrome.

D Louvel 1, M Delvaux 1, A Felez 1, J Fioramonti 1, L Bueno 1, Y Lazorthes 1, J Frexinos 1
PMCID: PMC1383401  PMID: 9014776

Abstract

AIM: The effects of oxytocin on colonic perception of intraluminal distension were evaluated in 26 patients with irritable bowel syndrome (IBS), using a flaccid bag placed in the descending colon and connected to a computerised barostat. METHOD: Symptomatic responses (first sensation and pain) were evaluated during isobaric distensions (4 mm Hg increments, five minute duration, five minute interval with return to zero pressure between each step), performed automatically by the barostat, during a continuous infusion of placebo or various doses of oxytocin (10, 20, 30, and 50 mU/min). RESULTS: The distension pressure (mean (SD)) required to induce a first abdominal sensation was 17.3 (5.5) mm Hg on placebo, 19.9 (5.8) on oxytocin 10 mU/min (NS), 22.3 (6.0) mm Hg on oxytocin 20 mU/min (p < 0.01), 23.1 (6.6) mm Hg on oxytocin 30 mU/min (p < 0.01), and 24.0 (7.1) mm Hg on oxytocin 50 mU/min (p < 0.01). The distension pressure required to induce pain was 24.8 (6.3) mm Hg on placebo, 26.0 (5.8) on oxytocin 10 mU/min (NS), 33.3 (7.8) mm Hg on oxytocin 20 mU/min (p < 0.01), 34.2 (7.6) mm Hg on oxytocin 30 mU/min (p < 0.01), and 34.3 (7.9) mm Hg on oxytocin 50 mU/ min (p < 0.01). Compliance curves were not different after placebo and oxytocin injection at the different doses. Naloxone did not inhibit the effect of oxytocin. Oxytocin also did not alter somatic perception, characterised by the RIII reflex at the level of the biceps femori. CONCLUSIONS: Oxytocin significantly increases thresholds for visceral perception in IBS patients at doses equal or to greater than 20 mU/min, possibly by acting at the level of visceral afferents.

Full text

PDF
741

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arletti R., Benelli A., Bertolini A. Influence of oxytocin on nociception and morphine antinociception. Neuropeptides. 1993 Mar;24(3):125–129. doi: 10.1016/0143-4179(93)90075-l. [DOI] [PubMed] [Google Scholar]
  2. Bazzocchi G., Ellis J., Villanueva-Meyer J., Jing J., Reddy S. N., Mena I., Snape W. J., Jr Postprandial colonic transit and motor activity in chronic constipation. Gastroenterology. 1990 Mar;98(3):686–693. doi: 10.1016/0016-5085(90)90289-d. [DOI] [PubMed] [Google Scholar]
  3. Berntson G. G., Berson B. S. Antinociceptive effects of intraventricular or systemic administration of vasopressin in the rat. Life Sci. 1980 Feb 11;26(6):455–459. doi: 10.1016/0024-3205(80)90165-4. [DOI] [PubMed] [Google Scholar]
  4. Bradette M., Delvaux M., Staumont G., Fioramonti J., Bueno L., Frexinos J. Evaluation of colonic sensory thresholds in IBS patients using a barostat. Definition of optimal conditions and comparison with healthy subjects. Dig Dis Sci. 1994 Mar;39(3):449–457. doi: 10.1007/BF02088327. [DOI] [PubMed] [Google Scholar]
  5. Bradette M., Delvaux M., Staumont G., Fioramonti J., Bueno L., Frexinos J. Octreotide increases thresholds of colonic visceral perception in IBS patients without modifying muscle tone. Dig Dis Sci. 1994 Jun;39(6):1171–1178. doi: 10.1007/BF02093780. [DOI] [PubMed] [Google Scholar]
  6. Bradette M., Pare P., Douville P., Morin A. Visceral perception in health and functional dyspepsia. Crossover study of gastric distension with placebo and domperidone. Dig Dis Sci. 1991 Jan;36(1):52–58. doi: 10.1007/BF01300087. [DOI] [PubMed] [Google Scholar]
  7. Bueno L., Fioramonti J., Ruckebusch Y., Frexinos J., Coulom P. Evaluation of colonic myoelectrical activity in health and functional disorders. Gut. 1980 Jun;21(6):480–485. doi: 10.1136/gut.21.6.480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Camilleri M., Neri M. Motility disorders and stress. Dig Dis Sci. 1989 Nov;34(11):1777–1786. doi: 10.1007/BF01540058. [DOI] [PubMed] [Google Scholar]
  9. Cook I. J., van Eeden A., Collins S. M. Patients with irritable bowel syndrome have greater pain tolerance than normal subjects. Gastroenterology. 1987 Oct;93(4):727–733. doi: 10.1016/0016-5085(87)90434-3. [DOI] [PubMed] [Google Scholar]
  10. Frexinos J., Fioramonti J., Bueno L. Colonic myoelectrical activity in IBS painless diarrhoea. Gut. 1987 Dec;28(12):1613–1618. doi: 10.1136/gut.28.12.1613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hachet T., Caussette M. A multifunction and programmable computerized barostat. Gastroenterol Clin Biol. 1993;17(5):347–351. [PubMed] [Google Scholar]
  12. Kordower J. H., Bodnar R. J. Vasopressin analgesia: specificity of action and non-opioid effects. Peptides. 1984 Jul-Aug;5(4):747–756. doi: 10.1016/0196-9781(84)90017-2. [DOI] [PubMed] [Google Scholar]
  13. Kovács G. L., Horváth Z., Sarnyai Z., Faludi M., Telegdy G. Oxytocin and a C-terminal derivative (Z-prolyl-D-leucine) attenuate tolerance to and dependence on morphine and interact with dopaminergic neurotransmission in the mouse brain. Neuropharmacology. 1985 May;24(5):413–419. doi: 10.1016/0028-3908(85)90026-7. [DOI] [PubMed] [Google Scholar]
  14. Kovács G. L., Sarnyai Z., Izbéki F., Szabó G., Telegdy G., Barth T., Jost K., Brtnik F. Effects of oxytocin-related peptides on acute morphine tolerance: opposite actions by oxytocin and its receptor antagonists. J Pharmacol Exp Ther. 1987 May;241(2):569–574. [PubMed] [Google Scholar]
  15. Kovács G. L., Sarnyai Z., Szabó G., Telegdy G. Development of morphine tolerance under tonic control of brain oxytocin. Drug Alcohol Depend. 1986 Jul;17(4):369–375. doi: 10.1016/0376-8716(86)90087-6. [DOI] [PubMed] [Google Scholar]
  16. Lundeberg T., Meister B., Björkstrand E., Uvnäs-Moberg K. Oxytocin modulates the effects of galanin in carrageenan-induced hyperalgesia in rats. Brain Res. 1993 Apr 16;608(2):181–185. doi: 10.1016/0006-8993(93)91456-3. [DOI] [PubMed] [Google Scholar]
  17. Lémann M., Dederding J. P., Flourié B., Franchisseur C., Rambaud J. C., Jian R. Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia. The irritable stomach syndrome. Dig Dis Sci. 1991 Sep;36(9):1249–1254. doi: 10.1007/BF01307517. [DOI] [PubMed] [Google Scholar]
  18. Madrazo I., Franco-Bourland R. E., León-Meza V. M., Mena I. Intraventricular somatostatin-14, arginine vasopressin, and oxytocin: analgesic effect in a patient with intractable cancer pain. Appl Neurophysiol. 1987;50(1-6):427–431. doi: 10.1159/000100753. [DOI] [PubMed] [Google Scholar]
  19. Mathias J. R., Clench M. H., Reeves-Darby V. G., Fox L. M., Hsu P. H., Roberts P. H., Smith L. L., Stiglich N. J. Effect of leuprolide acetate in patients with moderate to severe functional bowel disease. Double-blind, placebo-controlled study. Dig Dis Sci. 1994 Jun;39(6):1155–1162. doi: 10.1007/BF02093778. [DOI] [PubMed] [Google Scholar]
  20. Mathias J. R., Clench M. H., Roberts P. H., Reeves-Darby V. G. Effect of leuprolide acetate in patients with functional bowel disease. Long-term follow-up after double-blind, placebo-controlled study. Dig Dis Sci. 1994 Jun;39(6):1163–1170. doi: 10.1007/BF02093779. [DOI] [PubMed] [Google Scholar]
  21. Millan M. J., Schmauss C., Millan M. H., Herz A. Vasopressin and oxytocin in the rat spinal cord: analysis of their role in the control of nociception. Brain Res. 1984 Sep 10;309(2):384–388. doi: 10.1016/0006-8993(84)90610-3. [DOI] [PubMed] [Google Scholar]
  22. Prior A., Read N. W. Reduction of rectal sensitivity and post-prandial motility by granisetron, a 5 HT3-receptor antagonist, in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 1993 Apr;7(2):175–180. doi: 10.1111/j.1365-2036.1993.tb00087.x. [DOI] [PubMed] [Google Scholar]
  23. Richter J. E., Barish C. F., Castell D. O. Abnormal sensory perception in patients with esophageal chest pain. Gastroenterology. 1986 Oct;91(4):845–852. doi: 10.1016/0016-5085(86)90685-2. [DOI] [PubMed] [Google Scholar]
  24. Ritchie J. Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome. Gut. 1973 Feb;14(2):125–132. doi: 10.1136/gut.14.2.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Rogers R. C., Hermann G. E. Oxytocin, oxytocin antagonist, TRH, and hypothalamic paraventricular nucleus stimulation effects on gastric motility. Peptides. 1987 May-Jun;8(3):505–513. doi: 10.1016/0196-9781(87)90017-9. [DOI] [PubMed] [Google Scholar]
  26. Sullivan M. A., Cohen S., Snape W. J., Jr Colonic myoelectrical activity in irritable-bowel syndrome. Effect of eating and anticholinergics. N Engl J Med. 1978 Apr 20;298(16):878–883. doi: 10.1056/NEJM197804202981604. [DOI] [PubMed] [Google Scholar]
  27. Swarbrick E. T., Hegarty J. E., Bat L., Williams C. B., Dawson A. M. Site of pain from the irritable bowel. Lancet. 1980 Aug 30;2(8192):443–446. doi: 10.1016/s0140-6736(80)91885-1. [DOI] [PubMed] [Google Scholar]
  28. Welgan P., Meshkinpour H., Beeler M. Effect of anger on colon motor and myoelectric activity in irritable bowel syndrome. Gastroenterology. 1988 May;94(5 Pt 1):1150–1156. doi: 10.1016/0016-5085(88)90006-6. [DOI] [PubMed] [Google Scholar]
  29. Whitehead W. E., Engel B. T., Schuster M. M. Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipation-predominant patients. Dig Dis Sci. 1980 Jun;25(6):404–413. doi: 10.1007/BF01395503. [DOI] [PubMed] [Google Scholar]
  30. Whitehead W. E., Holtkotter B., Enck P., Hoelzl R., Holmes K. D., Anthony J., Shabsin H. S., Schuster M. M. Tolerance for rectosigmoid distention in irritable bowel syndrome. Gastroenterology. 1990 May;98(5 Pt 1):1187–1192. doi: 10.1016/0016-5085(90)90332-u. [DOI] [PubMed] [Google Scholar]
  31. Willer J. C., Boureau F., Albe-Fessard D. Supraspinal influences on nociceptive flexion reflex and pain sensation in man. Brain Res. 1979 Dec 21;179(1):61–68. doi: 10.1016/0006-8993(79)90489-x. [DOI] [PubMed] [Google Scholar]
  32. Willer J. C. Comparative study of perceived pain and nociceptive flexion reflex in man. Pain. 1977 Feb;3(1):69–80. doi: 10.1016/0304-3959(77)90036-7. [DOI] [PubMed] [Google Scholar]
  33. Willer J. C., Roby A., Le Bars D. Psychophysical and electrophysiological approaches to the pain-relieving effects of heterotopic nociceptive stimuli. Brain. 1984 Dec;107(Pt 4):1095–1112. doi: 10.1093/brain/107.4.1095. [DOI] [PubMed] [Google Scholar]
  34. Yamazoe M., Shiosaka S., Shibasaki T., Ling N., Tateishi K., Hashimura E., Hamaoka T., Kimmel J. R., Matsuo H., Tohyama M. Distribution of six neuropeptides in the nucleus tractus solitarii of the rat: an immunohistochemical analysis. Neuroscience. 1984 Dec;13(4):1243–1266. doi: 10.1016/0306-4522(84)90296-3. [DOI] [PubMed] [Google Scholar]
  35. de Caestecker J. S., Pryde A., Heading R. C. Site and mechanism of pain perception with oesophageal balloon distension and intravenous edrophonium in patients with oesophageal chest pain. Gut. 1992 May;33(5):580–586. doi: 10.1136/gut.33.5.580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. von der Ohe M. R., Camilleri M., Kvols L. K. A 5HT3 antagonist corrects the postprandial colonic hypertonic response in carcinoid diarrhea. Gastroenterology. 1994 May;106(5):1184–1189. doi: 10.1016/0016-5085(94)90008-6. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES